Navigation Links
Theramed Corporation to Launch Glenveigh Products, ebb™ and jetty™ at the Society of Obstetricians and Gynecologists of Canada

MISSISSAUGA, Ontario, June 14, 2011 /PRNewswire/ -- Theramed Corporation ("Theramed") announces that it will launch ebb™ and jetty™ at the 67th Clinical Meeting of the Society of Obstetricians and Gynecologists of Canada. The two newly developed medical devices are to be used to advance the practice of obstetrics, from Glenveigh International, LLC ("Glenveigh"). Both medical device products have been approved for sale by Health Canada, and Theramed will begin distributing these products on June 17th. "We are very excited to partner with Glenveigh Medical in advancing obstetrics for healthy moms and babies in Canada," commented Bill Baugh, Theramed's Chief Executive Officer.

About the ebb™ Complete Tamponade System

ebb™ is a complete tamponade solution for postpartum hemorrhage. Designed by world-renowned maternal-fetal medicine specialists Michael A. Belfort and Gary A. Dildy, the ebb™ balloon is made of a malleable yet extremely strong material, allowing ebb™ to expand and conform to any uterine shape. ebb™ also features a vaginal balloon to control vaginal bleeding and act as an anchor to support the uterine balloon. External ports allow independent control of inflation, deflation, irrigation, and drainage.

About the jetty™ Vaginal Repair Balloon

jetty™ is indicated for use during episiotomy and vaginal laceration repair to temporarily prevent the postpartum discharge of fluids from the vagina in order to assist with the repair procedure. jetty™ provides clarity and cleanliness for a timely, effective repair, and it eliminates the need for vaginal packing with gauze or sponges.

About Theramed Corporation

Theramed Corporation, headquartered in Mississauga, Ontario, is a specialty pharmaceutical company, focused on the development, acquisition, in-licensing, marketing, and distribution of medical products in Canada. The Company is dedicated to bringing new-to-market and well-established healthcare innovations to Canadian Physicians and Hospitals, be these Pharmaceuticals, Biotech products, or Medical Devices. The company currently markets Delatestryl®, Viroptic®, CollatampG® and FSME-IMMUN®.

About Glenveigh International, LLC

Glenveigh is a life science and medical technology company focused on advancing the practice of obstetrics, with aspirations to rapidly become the market leader in the OB/GYN field. Formed in 2004 by a maternal-fetal medicine (MFM) specialist, Glenveigh is founded on the core mission of improving the lives of pregnant mothers and their babies.

For more information on ebb™ or jetty™, marketing medical innovations in Canada, or on Theramed, please contact:

T.W. (Bill) Baugh III
President and CEO
Tel: 905-564-5009 or 800-305-4441

SOURCE Theramed Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Theramed Secures Exclusive Canadian Distribution Rights for Two Novel Obstetrics Products from Glenveigh
2. Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST® cTnI-II (cardiac Troponin I) Test in U.S.
3. Spectros Corporation Introduces Continuum®, a Broadband Infrared Sensor for Brain and Gut Oximetry
4. AmbiCom Forms Joint Alliance With E-Care Technology Corporation
5. Volcano Corporation Presentation at William Blair Conference to be Webcast
6. President of Minntech Corporation Injured in Plane Crash
7. Translational Sciences Corporation to Launch OncoTrac™ at the American Society of Clinical Oncology (ASCO) Annual Meeting
8. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
9. Volcano Corporation Presentation at Goldman Sachs Conference to be Webcast
10. EMIT Corporation Receives FDA 510(k) Clearance for HypothermX™ Blood and Fluid Warmer.
11. Statement From Volcano Corporation on Latest St. Jude Lawsuit
Post Your Comments:
(Date:12/1/2015)... , Dec. 1, 2015  Athletic apparel ... founder have agreed to pay $1.35 million to ... advertised the company,s copper-infused compression clothing would relieve ... arthritis and other diseases. Tommie ... requires the company and its founder and chairman ...
(Date:12/1/2015)... 2015 Pharma Tech Outlook recently conducted a ... Data Management Solution Providers - 2015 .  After careful ... CEOs, CIOs, VCs, analysts, and the Pharma Tech Outlook ... top 10 clinical data management solution providers (check out ... and 36 respectively). --> ...
(Date:12/1/2015)... and PITTSBURGH , Dec. ... announced that it expects to be the first to ... funded by international donors, TLE400 (Tenofovir Disoproxyl Fumarate 300 ... for $99 per patient, per year. Mylan partnered with ... The significantly reduced price could generate savings of tens ...
Breaking Medicine Technology:
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... States, today announced that its iconic bottle has won top honors in Beverage World ... The Company also announced that it has been selected as a 2015 U.S.A. ...
(Date:12/1/2015)... Houston, TX (PRWEB) , ... December 01, 2015 , ... ... owner of Vitenas Cosmetic Surgery, has been named by MedEsthetics magazine as the Best ... best of the best among the many elite aesthetic physicians honored by the industry ...
(Date:12/1/2015)... ... 01, 2015 , ... Speech and physical therapies are traditionally ... technologies and under the right circumstances, these practices can be merged. This ... to his or her therapeutic sessions, as well as gives the physical and ...
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per ... decreases in utilization of hospital and nonhospital care, according to a recent study by ... for Louisiana, 16th Edition , found medical payments per claim with more than seven ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... identification tests to continue the expansion of the company’s growing product line of ... for Chinook (Oncorhynchus tshawytscha) and Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer ...
Breaking Medicine News(10 mins):